483 Reverse Lookup | Warning Letters | Regulatory Action Reports | OpenFDA: CAERs | Recalls
This chart indicates the total number of observations by fiscal year found during FDA inspections of dietary supplement companies under 21 CFR 111 CGMP's, and includes adverse event reporting data.
DISCLAIMER: These charts are compiled from FDA data. The author does not guarantee that all information provided is accurate and complete, as FDA may redact certain information from the published datasets. Please confirm your conclusions by checking at the FDA web site: Inspection Classifications and Inspection Observations or make a FOI request to FDA. I will be glad to make a FOI request on your behalf, please contact me.
All charts and tables are ©2018 Marian Boardley Consulting LLC. If you found this information useful, please consider making a $5 contribution (suggested) at paypal.me/MarianBoardley. Thank You!